Search the Site

 
News and views

Stay informed

Home / News and views
Back
News > News Article

12 April 2019

Brexit ‘On Deal’ preparations continue – no change to advice for primary eye care

The Department of Health and Social Care (DHSC) continue contingency planning for the event of a No deal Brexit and have issued updated advice.

The advice outlines what has been done nationally to assess the potential risks to primary care and gives direction on the actions that contractors delivering primary care still need to take locally. It is important for everyone working in primary care to understand the actions that are needed.  For community optical practices there is no change.

  • Primary care contractors do not need to change their behaviour in terms of ordering stocks or engaging with suppliers, as this work has been undertaken nationally. This means contractors should not stockpile medicines, medical devices or clinical consumables and should advise patients not to do so either.
  • For medical devices and clinical consumables that your practice or pharmacy orders directly from companies based in the EU on a short buy clonazepam 2 mg online lead time basis (i.e. 24 to 72 hours), you should plan for lead times of around three days longer on these items only. Please note that this advice does not apply to medicines and does not apply to products ordered via a wholesaler.
  • Primary care contractors will not be asked to take part in the daily situation reporting that NHS England and NHS Improvement will be undertaking. However, we do ask that any issues or concerns are escalated as appropriate, details of whom to escalate to below and are also at the end of the updated guidance.

Providers who fear a supply shortage of essential medicines and medical devices to contact the National Supply Disruption Response (NSDR) centre using the following contacts:

Free Phone in the UK: 0800 915 9964
Direct Line: 0044 (0) 191 283 6543
Email[email protected]

Share this page
For more information please contact:
FODO
FODO

Subscribe

* indicates required
I confirm I would like to receive the following newsletter:

Press enquiries

Media enquiries should be directed to [email protected] or call 020 7298 5151.

We are happy to put you in touch with our expert policy advisers who can comment on a variety of issues.

You can also follow us on Twitter and LinkedIn.